Title A cohort study of exposure to antihyperglycemic therapy and survival in patients with lung cancer /
Authors Danila, Edvardas ; Linkevičiūtė-Ulinskienė, Donata ; Zablockis, Rolandas ; Gruslys, Vygantas ; Cicėnas, Saulius ; Smailytė, Giedrė
DOI 10.3390/ijerph17051747
Full Text Download
Is Part of International journal of environmental research and public health.. Basel : MDPI AG. 2020, vol. 17, no. 5, p. [1-12].. ISSN 1661-7827. eISSN 1660-4601
Keywords [eng] diabetes ; insulin ; lung cancer ; metformin
Abstract [eng] We evaluated the effect of antihyperglycemic therapy on the survival of patients with lung cancer (LC). The analysis included patients with LC and concomitant type 2 diabetes. 15,929 patients were classified into five groups: metformin users, insulin users, metformin and insulin users, sulphonylurea users and non-diabetic group. A multivariate analysis showed that exposure to either metformin or to insulin was associated with a lower risk of LC-specific mortality, and this approached statistical significance (HR 0.82, 95% CI 0.72-92 for metformin and HR 0.65, 95% CI 0.44-95 for insulin). When deaths from all causes were considered, only metformin exposure was associated with a significantly lower risk of death (HR 0.82, 95% CI 0.73-0.92). Users of sulphonylurea were at a higher risk of LC-specific and overall mortality (HRs 1.19, 95% CI 0.99-1.43 and 1.22, 95% CI 1.03-1.45). Our study shows a positive effect of metformin on the survival of patients with LC. Moreover, our results show that exposure to insulin was associated with a lower risk of LC-specific mortality, but not with deaths from all causes. The study results suggested that users of sulphonylurea may be at a higher risk of LC-specific and overall mortality.
Published Basel : MDPI AG
Type Journal article
Language English
Publication date 2020
CC license CC license description